Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.
Open Access
- 1 February 1984
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 73 (2) , 556-565
- https://doi.org/10.1172/jci111243
Abstract
The in vitro regulation of adult human monocyte DR antigen expression was studied. Normally about 75% of freshly obtained human peripheral blood monocytes express DR antigens as determined by anti-DR and complement-mediated cytotoxicity assays. DR expression on monocytes in unfractionated peripheral blood mononuclear cell cultures persisted to variable degrees for up to 5 d of incubation. However, when the mononuclear cells were thoroughly depleted of nonadherent cells, cultured monocytes consistently exhibited progressively decreased DR expression over 2-5 d of incubation. Readdition of nonadherent cells to the adherent cell population prevented or delayed this decrease in monocyte DR antigen expression. Thus, monocyte DR expression diminished markedly during in vitro incubation; however, the presence of nonadherent cells somehow interfered with this process. In other experiments, peripheral adherent monocytes, which had been cultured for 2-3 d to reduce their DR expression, could be induced to reexpress DR antigens after 2 d of incubation with unpurified lymphokine-containing culture supernatants, recombinant human interferon-alpha, or recombinant human gamma interferon (IFN-gamma). The reinduction of DR expression on human monocytes by lymphokines was abrogated by an antiserum produced to the synthetic N-terminal amino acids of human IFN-gamma, indicating that IFN-gamma is the active mediator in the lymphokine-containing preparations. Monocytes cultured with lymphokines or recombinant interferons also could initiate a significantly greater mixed lymphocyte response than control monocytes. Thus, IFN-gamma-containing lymphokines and recombinant interferons are required to induce human monocyte DR expression and accessory cell capacity in vitro, since in their absence monocytes become DR antigen-deficient. Finally, incubation of unfractionated human mononuclear cells with anti-human IFN-gamma also promoted the loss of monocyte DR expression. These findings suggest that resting lymphocytes are probably capable of producing sufficient IFN-gamma in vitro to result in the maintenance of the monocyte DR phenotype.This publication has 37 references indexed in Scilit:
- Spontaneous T-cell lymphokine production and enhanced macrophage la expression and tumoricidal acitivity in MRL-Ipr miceClinical Immunology and Immunopathology, 1982
- Lectin-dependent T-lymphocyte and natural killer cytotoxic deficiencies in human newbornsCellular Immunology, 1982
- Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte InterferonScience, 1982
- Human dendritic cells. Enrichment and characterization from peripheral bloodThe Journal of Experimental Medicine, 1982
- Concomitant induction of the cell surface expression of Ia determinants and accessory cell function by a murine macrophage tumor cell line.The Journal of Experimental Medicine, 1982
- Description of a monoclonal antibody defining an HLA allotypic determinant that includes specificities within the B5 cross-reacting groupHuman Immunology, 1982
- A defect in the antigen-presenting function of macrophages from neonatal miceNature, 1979
- Sharing of Ia Antigens between SpeciesScandinavian Journal of Immunology, 1979
- HLA-D Restriction of the Macrophage-Dependent Response of Immune Human T Lymphocytes to PPD in Vitro: Inhibition by Anti-HLA-DR AntiseraScandinavian Journal of Immunology, 1978
- Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen.The Journal of Experimental Medicine, 1976